FIGURE 4 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

<p>Characterization of BM cell populations of patients with MDS based on scProt-seq data. <b>A,</b> UMAP of BM cells from all MDS samples colored by abundance of the depicted proteins. <b>B,</b> UMAP of BM cells from all MDS samples colored by cell type annotation. <b>C,</b> Cell type proportions at diagnosis and after AZA treatment in responders. *, scCODA FDR <0.1. <b>D,</b> UMAPs at diagnosis and after AZA for all the responder patients. Dx, diagnosis; Aza, after AZA treatment.</p>